Advertisement
Advertisement

XAIR

XAIR logo

Beyond Air, Inc. Common Stock

0.3556
USD
0
-1.01%
Feb 21, 15:59 UTC -5
Closed
exchange

After-Market

0.35

-0.01
-1.57%

Beyond Air, Inc. Common Stock Profile

About

Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.

Info & Links

CEO

Steven Lisi

Headquarters

900 STEWART AVENUE, SUITE 301
GARDEN CITY, NY 11530, UNITED STATES

Sector

Medical

Auditor

Marcum LLP

Share holders

105

Employees

107

Beyond Air, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

30.90M

Enterprise Value

26.12M

Enterprise Value/EBITDA(ttm)

-0.58

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

8.09

Price to Book(mrq)

1.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-78.47%

Operating Margin(ttm)

-1730.00%

Profit Margin(ttm)

-1898.09%

Return on Equity(ttm)

-226.01%

Return on Invested Capital(ttm)

-182.13%

Return on Assets(ttm)

-109.75%

Income Statement

Revenue(ttm)

3.02M

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

-2.15M

EBITDA(ttm)3

-45.36M

Net Income Available to Common(ttm)

-52.30M

Diluted EPS(ttm)

-1.06

Share Statistics

Beta (5Y Monthly)

-0.15

52-Week Change

-80.88%

S&P 500 52-Week Change

18.61%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

88.28M

Dividend Yield

0.00%

Float4

54.97M

% Held by Insiders

20.10%

% Held by Institutions

31.50%

Balance Sheet

Total Cash(mrq)

11.18M

Total Cash Per Share(mrq)

0.13

Total Debt(mrq)

60.00K

Total Debt/Equity(mrq)

0.33%

Current Ratio(mrq)

3.56%

Quick Ratio(mrq)

3.12%

Book Value Per Share(mrq)

0.25

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.35

Free Cash Flow(ytd)

-35.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement